Roundtable discussion: Targeting abdominal obesity to reduce cardiovascular risk in patients with type 2 diabetes metlitus

被引:39
作者
Aronne, Louis J.
Henry, Robert R.
Bergman, Richard N.
Woods, Stephen C.
Hollander, Priscilla
机构
[1] Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA
[2] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA
[3] San Diego VA Med Ctr, Diabet & Metab Sect, San Diego, CA USA
[4] Univ So Calif, Keck Sch Med, Los Angeles, CA USA
[5] Univ Cincinnati, Obes Res Ctr, Cincinnati, OH USA
[6] Baylor Univ, Med Ctr, Ruth Collins Diabet Ctr, Dallas, TX USA
关键词
D O I
10.1016/j.amjmed.2006.11.015
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
引用
收藏
页码:S29 / S32
页数:4
相关论文
共 2 条
[1]
Central leptin acutely reverses diet-induced hepatic insulin resistance [J].
Pocai, A ;
Morgan, K ;
Buettner, C ;
Gutierrez-Juarez, R ;
Obici, S ;
Rossetti, L .
DIABETES, 2005, 54 (11) :3182-3189
[2]
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients:: 1-year experience from the RIO-Europe study [J].
Van Gaal, LF ;
Rissanen, AM ;
Scheen, AJ ;
Ziegler, O ;
Rössner, S .
LANCET, 2005, 365 (9468) :1389-1397